The year 2025 was anything but ordinary. The US administration’s introduction of tariffs sent shockwaves through global trade ...

As 2025 comes to a close, we ask the only question that matters - are you satisfied with your returns over the last 12 months ...

Two ASX gold miners illustrate the opportunity well: Northern Star Resources ( ASX: NST), which is valued cheaply despite ...

Antipodes Healthcare Portfolio Manager, Nick Cameron highlighted why Antipodes believes Merck & Co is entering 2026 at an ...

After a decade of extraordinary growth, Australia’s ETF industry entered 2025 in a more mature phase of its evolution. No ...

The forces driving Australia’s crypto market today aren’t the ones most people assume. Older Australians and women are now ...

For those playing along at home, the stock is 4DMedical Ltd ( ASX: 4DX), which has skyrocketed more than 1,000% in the second ...

The bull market is not over, but it is changing. Two major brokers explain why selectivity and earnings matter more than ever.

MYEFO delivered a modest deficit upgrade, but long-term spending pressures continue to cloud Australia’s fiscal outlook.

With hybrids phasing out, investors are finding attractive yields in a range of new listed investments coming to market.

Despite being tipped as an income name, MQG finished 2025 with a -5.58% total return, as a 9.06% share price decline ...